According to an Israeli study, the treatment of medical marijuana is helping improve the conditions of children who have cerebral palsy.

The study, which was done by Wolfson Medical Center near Tel Aviv, Israel and conducted with the MMJ company Tikun Olam, started around three years ago. It has studied so far 36 children with their ages ranging from 1 to 17.

The study found that treatment with cannabis oil reduced symptoms in children with cerebral palsy and improved children’s motor skills. Sleep quality, as well as bowel movements were also found to improve.

It also improved their sleep quality, bowel movements and general mood.
Twenty of the children have completed the testing stage, and many of them are continuing treatment with medical marijuana.

Luba Blumkin, a child neurologist and the leader of the project stated, “We included the hardest cases in the study, with the highest level of motor disorders.”

“Usually the motor disorder comes with other problems, like problems with bowel movements that cause pain, orthopedic problems that cause pain, and problems in swallowing and chewing, which make it necessary to feed some of the children by tube directly into the stomach,” said Blumkin.

“The pain, which increases with time, causes sleeping problems and makes treatment difficult because every touch is painful.”

“We used several evaluation indexes for the treatment’s effectiveness, such as the effect on the spasticity (muscle contraction), dystonia (involuntary movement) and motor changes, like if the child rolls over or stretches his hand out better. We also checked effects like mood, sleep, constipation, pain and quality of life,” Blumkin said to Haaretz, a daily newspaper in Israeel.

According to Blumkin, “The most prominent difference statistically was in motor function. There was also less pain and improvement in sleep and bowel movements.”

 


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

From the Archives: Mr. Randall Goes to Washington (1980)
22 October 2023
Bill Clinton Hails ‘Very Encouraging’ CBD Clinical Trial
13 July 2022
PURA Expects To Sign First Contracts This Month Contributing To $1M 2022 Revenue Forecast
02 December 2021